Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Schrama, D; Voigt, H; Eggert, AO; Xiang, R; Zhou, H; Schumacher, TNM; Andersen, MH; Straten, PT; Reisfeld, RA; Becker, JC.
Immunological tumor destruction in a murine melanoma model by targeted LT alpha independent of secondary lymphoid tissue
CANCER IMMUNOL IMMUNOTHER. 2008; 57(1): 85-95. Doi: 10.1007/s00262-007-0352-x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leading authors Med Uni Graz
Schrama David
Co-authors Med Uni Graz
Becker Jürgen Christian
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: We previously demonstrated that targeting lymphotoxin alpha (LTalpha) to the tumor evokes its immunological destruction in a syngeneic B16 melanoma model. Since treatment was associated with the induction of peritumoral tertiary lymphoid tissue, we speculated that the induced immune response was initiated at the tumor site. METHODS AND RESULTS: In order to directly test this notion, we analyzed the efficacy of tumor targeted LTalpha in LTalpha knock-out (LTalpha(-/-)) mice which lack peripheral lymph nodes. To this end, we demonstrate that tumor-targeted LTalpha mediates the induction of specific T-cell responses even in the absence of secondary lymphoid organs. In addition, this effect is accompanied by the initiation of tertiary lymphoid tissue at the tumor site in which B and T lymphocytes are compartmentalized in defined areas and which harbor expanded numbers of tumor specific T cells as demonstrated by in situ TRP-2/K(b) tetramer staining. Mechanistically, targeted LTalpha therapy seems to induce changes at the tumor site which allows a coordinated interaction of immune competent cells triggering the induction of tertiary lymphoid tissue. CONCLUSION: Thus, our data demonstrate that targeted LTalpha promotes an accelerated immune response by enabling the priming of T cells at the tumor site.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Gangliosides - immunology
Humans -
Immunohistochemistry -
Lymphocyte Activation - immunology
Lymphocytes, Tumor-Infiltrating -
Lymphoid Tissue - cytology Lymphoid Tissue - immunology
Lymphotoxin-alpha - immunology Lymphotoxin-alpha - therapeutic use
Melanoma, Experimental - immunology Melanoma, Experimental - therapy
Mice -
Mice, Inbred C57BL -
Mice, Knockout -
Recombinant Fusion Proteins - immunology Recombinant Fusion Proteins - therapeutic use
T-Lymphocytes - immunology

Find related publications in this database (Keywords)
T cells
cytokines
tumor immunity
lymphotoxin alpha knock-out mice
antibody
© Med Uni GrazImprint